Radioisotope manufacturer Ion Beam Applications (IBA) of Louvain-la-Neuve, Belgium, has opened a new facility for radiopharmaceutical R&D and production in Belgium.
Located in the city of Fleurus, the facility is on the site of the National Radioelements Institute (IRE). The facility has a 14-MeV cyclotron, which can be used for both very-high-level industrial production and for scientific research, according to the company.
IBA expects to supply radiopharmaceuticals for clinical trials throughput Europe, such as fluorine-18 fluorothymidine, fluoromisonidazole, F-18 choline, iodine-124, and copper-64. In 2008, the site will begin producing PET radiopharmaceuticals, mainly fluorodeoxyglucose.
The company said it invested more than 6 million euros ($8.2 million) to develop the site.
By AuntMinnie.com staff writers
April 20, 2007
Related Reading
IBt inks IBA distribution deal, April 18, 2007
IBA increases sales and profit in 2006, March 15, 2007
IBA to install cyclotron in India, February 26, 2007
IBA expands production capacity, January 19, 2007
IBA nets U.S. proton therapy order, January 8, 2007
Copyright © 2007 AuntMinnie.com
